Treating Multiple Myeloma by Targeting the NF-Kappa-B Pathway with Gadd45-Beta/MKK7 Inhibitors

Differentiation of Granulocytes and Macrophages

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Linda J Burns

Training and Mentorship of Hematologic Oncologists

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

Jonathan Hofmann

Pooled Investigation of Circulating Adiponectin and Multiple Myeloma and Immunoproliferative Diseases in the NCI Cohort Consortium

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Kenneth C Anderson

Molecular Sequelae of Myeloma-Bone Marrow Interactions: Therapeutic Applications

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Stephanie J Lee

Improving Outcomes Assessment in Chronic Graft versus Host Disease

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

Daniel M Sullivan

CRM1 INHIBITORS SENSITIZE MULTIPLE MYELOMA CELLS TO TOPOISOMERASE II AND PROTEASOME INHIBITORS

Multiple myeloma and immunoproliferative diseases

Steven M Lipkin

Whole Genome Sequencing to Discover Familial Myeloma Risk Genes

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies

Antoinette Stroup

PATTERNS OF CARE/QUALITY OF CARE STUDY : DIAGNOSIS YEAR 2014

Multiple myeloma and immunoproliferative diseases Leukaemia Colorectum

Nathaniel Rothman

DDT, PCBs, and Other Persistent Organohalide Chemicals in the JANUS Cohort

Trachea, bronchus and lung Thyroid Testis Prostate Pancreas Ovary Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Lip, oral cavity Leukaemia

Hematology and hematologic malignancies Pathology